Cornerstone Investment Partners’s Veracyte VCYT Stock Holding History

Cornerstone Investment Partners’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$451K	Sell	7,675 -368	-5%	-$15.4K	0.02%	111
2026 Q1	$259K	Buy	8,043 +1,843	+30%	+$68.2K	0.01%	206
2025 Q4	$261K	Buy	6,200 +4	+0.1%	+$161	0.01%	119
2025 Q3	$213K	Buy	+6,196	New	+$178K	0.01%	155
2025 Q1	–	Sell	-7,238	Closed	-$287K	–	266
2024 Q4	$287K	Buy	7,238 +4	+0.1%	+$151	0.01%	108
2024 Q3	$246K	Buy	+7,234	New	+$204K	0.01%	143
2020 Q1	–	Sell	-8,895	Closed	-$248K	–	220
2019 Q4	$248K	Buy	+8,895	New	+$230K	0.01%	120

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cornerstone Investment Partners's VCYT Position: Q2 2026 in Review

Cornerstone Investment Partners reduced its Veracyte (VCYT) stake by 4.6% in Q2 2026, selling an estimated $15.4K and leaving 7,675 shares worth $451K. The position accounts for 0.02% of the portfolio, ranked #111.

Cornerstone Investment Partners first reported a position in VCYT in Q4 2019 and has held it in 7 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Cornerstone Investment Partners held 7,675 shares of Veracyte worth $451K as of Q2 2026.
Cornerstone Investment Partners sold 368 Veracyte shares in Q2 2026, an estimated $15.4K.
Veracyte made up 0.02% of Cornerstone Investment Partners's portfolio in Q2 2026, its #111 holding.
Cornerstone Investment Partners first reported a position in Veracyte in Q4 2019 and has held it in 7 quarters since.
370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Cornerstone Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.